The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase
Open accessAbstract
The lipopeptide antifungal agents, echinocandins, papulacandins, and pneumocandins, kill Candida albicans by inhibiting glucan synthesis. For this fungus, there is a good correlation of in vitro enzyme inhibition with in vitro assays of MICs. Semisynthetic lipopeptides such as cilofungin, LY303366, L-693,989, and L-733,560 have activity in vivo against Aspergillus infections but appear to be inactive in broth dilution in vitro tests (MICs, > 128 micrograms/ml). To understand how compounds which lack activity in vitro can have good in vivo activity, we monitored the effect of pneumocandins on the morphology of Aspergillus fumigatus and A, flavus strains by light microscopy and electron microscopy and related the changes in growth to inhibition of glucan synthesis. Pneumocandin B0 caused profound changes in hyphal growth; light micrographs showed abnormally swollen germ tubes, highly branched hyphal tips, and many cells with distended balloon shapes. Aspergillus electron micrographs confirmed that lipopeptides produce changes in cell walls; drug-treated germlings showed very stubby growth with thick walls and a conspicuous dark outer layer which was much thicker in the subapical regions. The rest of the hyphal tip ultrastructure was unaffected by the drug, indicating considerable specificity for the primary target. The drug-induced growth alteration produced very compact clumps in broth dilution wells, making it possible to score the morphological effect macroscopically. The morphological changes could be assayed quantitatively by using conventional broth microdilution susceptibility assay conditions. We defined the endpoint as the lowest concentration required to produce the morphological effect and called it the minimum effective concentration to distinguish it from the no-growth endpoints used in MIC determinations. The minimum effective concentration assay was related to inhibition of glucan synthase activity in vitro and may provide a starting point for development of susceptibility testing methods for lipopeptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Cell Wall Chemistry, Morphogenesis, and Taxonomy of Fungi
Bartnicki-Garcia, S. (1968) · Annual Review of Microbiology · doi:10.1146/annurev.mi.22.100168.000511 · Cited by 1,574
Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P., Grieco, M. H., Sharkey, P. K., Thompson, S. E., Sugar, A. M., Tuazon, C. U., Fisher, J. F., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260202 · Cited by 631
Protoplasmic organization of hyphal tips among fungi: vesicles and Spitzenkorper.
Grove, S. N., & Bracker, C. E. (1970) · Journal of Bacteriology · doi:10.1128/jb.104.2.989-1009.1970 · Cited by 432 · cited 1×
“The concomitant reduction in the Spitzenkorpers suggests that they too represent a "snapshot" of a population of microvesicles in transit, a point not clear in previous studies of tip growth (23).”
BackgroundCollaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests
Espinel-Ingroff, A., Kish, C. W., Kerkering, T. M., Fromtling, R. A., Bartizal, K., Galgiani, J. N., Villareal, K., Pfaller, M. A., Gerarden, T., & Rinaldi, M. G. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.12.3138-3145.1992 · Cited by 243
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts
Fromtling, R. A., Galgiani, J. N., Pfaller, M. A., Espinel-Ingroff, A., Bartizal, K. F., Bartlett, M. S., Body, B. A., Frey, C., Hall, G., & Roberts, G. D. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.39 · Cited by 196
The Roles of Actin in Tip Growth of Fungi
Heath, I. B. (1990) · International Review of Cytology · doi:10.1016/s0074-7696(08)60672-5 · Cited by 161
Self-citationTreatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
Schmatz, D. M., Romancheck, M. A., Pittarelli, L. A., Schwartz, R. E., Fromtling, R. A., Nollstadt, K. H., Vanmiddlesworth, F. L., Wilson, K. E., & Turner, M. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5950 · Cited by 161
Echinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicans
Sawistowska-Schröder, E. T., Kerridge, D., & Perry, H. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81032-7 · Cited by 124
Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives
Bouffard, F. A., Zambias, R. A., Dropinski, J. F., Balkovec, J. M., Hammond, M. L., Abruzzo, G. K., Bartizal, K. F., Marrinan, J. A., & Kurtz, M. B. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00028a003 · Cited by 113
Self-citationIn vitro and in vivo anti-Candida activity and toxicology of LY121019.
Gordee, R. S., Zeckner, D. J., Ellis, L. F., Thakkar, A. L., & Howard, L. C. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1054 · Cited by 108
L-671,329, a new antifungal agent. I. Fermentation and isolation.
SCHWARTZ, R. E., GIACOBBE, R. A., Bland, J. A., & Monaghan, R. L. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.163 · Cited by 100
Shematek, E. M., & Cabib, E. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86117-3 · Cited by 96
Bartizal, K. F., Abruzzo, G. K., Trainor, C., Krupa, D. A., Nollstadt, K. H., Schmatz, D. M., Schwartz, R., Hammond, M. L., Balkovec, J. M., & VanMiddlesworth, F. L. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1648 · Cited by 93
A steady-state model for apical wall growth in fungi
Wessels, J. G. H. (1988) · Acta Botanica Neerlandica · doi:10.1111/j.1438-8677.1988.tb01576.x · Cited by 90
Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan
Borgia, P. T., & Dodge, C. L. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.2.377-383.1992 · Cited by 86
Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity
Taft, C. S., Stark, T., & Selitrennikoff, C. P. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1901 · Cited by 85
Szaniszlo, P. J., Kang, M. S., & Cabib, E. (1985) · Journal of Bacteriology · doi:10.1128/jb.161.3.1188-1194.1985 · Cited by 82
Lysis of growing yeast-form cells ofCandida albicansby echinocandin: A cytological study
Cassone, A., Mason, R. E., & Kerridge, D. (1981) · Medical Mycology · doi:10.1080/00362178185380161 · Cited by 82
Evidence that actin reinforces the extensible hyphal apex of the oomyceteSaprolegnia ferax
Jackson, S. L., & Heath, I. B. (1990) · PROTOPLASMA · doi:10.1007/bf01322647 · Cited by 78
Self-citationKreger, D. R., & Kopecká, M. (1976) · Journal of General Microbiology · doi:10.1099/00221287-92-1-207 · Cited by 76
Denning, D. W., & Stevens, D. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1329 · Cited by 76
[55] Fungal 1,3-β-glucan synthase
Cabib, E., & Kang, M. S. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)38057-7 · Cited by 67
Characterization of the 1,3- -glucan synthase of Aspergillus fumigatus
Beauvais, A., Drake, R. R., Ng, K., Diaquin, M., & Latgé, J. P. (1993) · Journal of General Microbiology · doi:10.1099/00221287-139-12-3071 · Cited by 66
Schmatz, D. M., Abruzzo, G. K., Powles, M., McFadden, D. C., Balkovec, J. M., Black, R. M., Nollstadt, K. H., & Bartizal, K. F. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1886 · Cited by 66
Orlean, P. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06885.x · Cited by 57
Gordee, R. S., Zeckner, D. J., Howard, L. C., Alborn, W. E., & Debono, M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb40415.x · Cited by 57
Biosynthesis of -Glucan Microfibrils by Cell-free Extracts from Saccharomyces cerevisiae
Larriba, G., MORALES, M., & Ruiz-Herrera, J. (1981) · Microbiology · doi:10.1099/00221287-124-2-375 · Cited by 55
L-671,329, a new antifungal agent. III. Structure determination.
Wichmann, C. F., Liesch, J. M., & Schwartz, R. E. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.168 · Cited by 49
Glucan Biosynthesis in Fungi and its Inhibition
Tkacz, J. S. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3274-3_19 · Cited by 40
LY121019 inhibits Neurospora crassa growth and (1-3)-.BETA.-D-glucan synthase.
Taft, C. S., & Selitrennikoff, C. P. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.697 · Cited by 40
TANG, J., & Parr, T. R. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.99 · Cited by 40
Beaulieu, D., Tang, J., Zeckner, D. J., & Parr, T. R. (1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb06088.x · Cited by 34
Bozzola, J. J., MEHTA, R. J., Nisbet, L. J., & Valenta, J. R. (1984) · Canadian Journal of Microbiology · doi:10.1139/m84-133 · Cited by 29
Fungal Cell Wall Synthesis and Assembly
Ruíz-Herrera, J., & Sentandreu, R. (1989) · Current topics in medical mycology · doi:10.1007/978-1-4612-3624-5_8 · Cited by 29
Papulacandin, a new antibiotic, active especially against yeasts
Gruner, J., & Traxler, P. M. (1977) · Cellular and Molecular Life Sciences · doi:10.1007/bf01936812 · Cited by 20
Effect of papulacandin B on glucan synthesis inParacoccidioides brasiliensis
Dávila, T., San-Blas, G., & San-Blas, F. (1986) · Medical Mycology · doi:10.1080/02681218680000291 · Cited by 17
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019
Pfaller, M. A., Gerarden, T., Yu, M., & Wenzel, R. P. (1988) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(88)90067-3 · Cited by 14
Drouhet, E., Dupont, B., Improvisi, L., Lesourd, M., & Prévost, M. (1990) · Medical Mycology · doi:10.1080/02681219080000541 · Cited by 12
Cited by
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Aspergillus Infections in Transplant Recipients
Singh, N., & Paterson, D. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.44-69.2005 · Cited by 579
Espinel-Ingroff, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2950-2956.1998 · Cited by 576
Metadata
- Authors
- Kurtz, M. B., Heath, I. B., Marrinan, J., Dreikorn, S., Onishi, J., & Douglas, C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1994-07
- Volume
- 38
- Issue
- 7
- Pages
- 1480-1489
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2098898162
- Cited by
- 320
- References
- 41
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.